Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 12:34 PM
Ignite Modification Date:
2025-12-24 @ 12:34 PM
NCT ID:
NCT02629861
Brief Summary:
The study is being conducted to evaluate two doses of TEV-48125 in adult patients with episodic migraine
Study:
NCT02629861
Study Brief:
Protocol Section:
NCT02629861